In March 2025, the company declared new designs for any direct-to-customer giving of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which might charge consumers $499 a month for use of the drug, a lot less than 50 percent the cost of the drug by way of other pharmaceutical distribution networks.[5